
Anand U. Desai
Examiner (ID: 10640, Phone: (571)272-0947 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1655, 1656, 1653 |
| Total Applications | 1419 |
| Issued Applications | 918 |
| Pending Applications | 162 |
| Abandoned Applications | 363 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18418547
[patent_doc_number] => 20230173005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => USE OF BROWN FLAMMULINA VELUTIPES EXTRACT FOR INHIBITING ACUTE KIDNEY INJURY CAUSED BY CISPLATIN
[patent_app_type] => utility
[patent_app_number] => 17/885279
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885279 | USE OF BROWN FLAMMULINA VELUTIPES EXTRACT FOR INHIBITING ACUTE KIDNEY INJURY CAUSED BY CISPLATIN | Aug 9, 2022 | Abandoned |
Array
(
[id] => 18970411
[patent_doc_number] => 20240050503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => FLOWER ESSENCE-CONTAINING MEDICAMENTS
[patent_app_type] => utility
[patent_app_number] => 17/817028
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817028 | FLOWER ESSENCE-CONTAINING MEDICAMENTS | Aug 2, 2022 | Abandoned |
Array
(
[id] => 18177519
[patent_doc_number] => 20230038248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => Personal Care Compositions
[patent_app_type] => utility
[patent_app_number] => 17/879364
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879364 | Personal Care Compositions | Aug 1, 2022 | Pending |
Array
(
[id] => 18452020
[patent_doc_number] => 20230193299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/812875
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812875 | COMPOSITIONS AND METHODS FOR SUCCINATE PRODUCTION | Jul 14, 2022 | Pending |
Array
(
[id] => 18901382
[patent_doc_number] => 20240016867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHOD FOR PRODUCING A CANNABIS INFUSED PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/862682
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862682 | METHOD FOR PRODUCING A CANNABIS INFUSED PRODUCT | Jul 11, 2022 | Pending |
Array
(
[id] => 18240362
[patent_doc_number] => 20230072673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => C-PEPTIDES AND PROINSULIN POLYPEPTIDES COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/810985
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810985 | C-PEPTIDES AND PROINSULIN POLYPEPTIDES COMPRISING THE SAME | Jul 5, 2022 | Abandoned |
Array
(
[id] => 18176978
[patent_doc_number] => 20230037707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => CO-PRODUCTION PATHWAY FOR 3-HPA AND ACETYL-COA DERIVATIVES FROM MALONATE SEMIALDEHYDE
[patent_app_type] => utility
[patent_app_number] => 17/856863
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856863 | Co-production pathway for 3-HPA and acetyl-CoA derivatives from malonate semialdehyde | Jun 30, 2022 | Issued |
Array
(
[id] => 20438817
[patent_doc_number] => 12509645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Cleaning compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/852456
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87831
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852456 | Cleaning compositions and uses thereof | Jun 28, 2022 | Issued |
Array
(
[id] => 17960044
[patent_doc_number] => 20220340624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => RNA-BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/830822
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 497
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830822 | RNA-BINDING PROTEIN | Jun 1, 2022 | Pending |
Array
(
[id] => 18545316
[patent_doc_number] => 11718656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Inducible caspases and methods for use
[patent_app_type] => utility
[patent_app_number] => 17/830773
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 6
[patent_no_of_words] => 25643
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830773 | Inducible caspases and methods for use | Jun 1, 2022 | Issued |
Array
(
[id] => 17882736
[patent_doc_number] => 20220298213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => IN VIVO ENGINEERED CEREBLON PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/750833
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750833 | IN VIVO ENGINEERED CEREBLON PROTEIN | May 22, 2022 | Abandoned |
Array
(
[id] => 17928798
[patent_doc_number] => 20220323923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => MICROCAPSULE AND PRODUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/731941
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731941 | MICROCAPSULE AND PRODUCTION METHOD THEREOF | Apr 27, 2022 | Abandoned |
Array
(
[id] => 19090982
[patent_doc_number] => 11952412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Exosome-based anticancer agent
[patent_app_type] => utility
[patent_app_number] => 17/712155
[patent_app_country] => US
[patent_app_date] => 2022-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5728
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712155 | Exosome-based anticancer agent | Apr 2, 2022 | Issued |
Array
(
[id] => 17928431
[patent_doc_number] => 20220323556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE
[patent_app_type] => utility
[patent_app_number] => 17/709166
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709166 | Dosing and administration of recombinant L-asparaginase | Mar 29, 2022 | Issued |
Array
(
[id] => 18178347
[patent_doc_number] => 20230039076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ALBUMIN VARIANTS AND CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/656728
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656728 | Albumin variants and conjugates | Mar 27, 2022 | Issued |
Array
(
[id] => 18128994
[patent_doc_number] => 11555193
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-17
[patent_title] => Gene ANSB knockout mutant of citrobacter werkmanii and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/700548
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 3394
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700548 | Gene ANSB knockout mutant of citrobacter werkmanii and application thereof | Mar 21, 2022 | Issued |
Array
(
[id] => 17852183
[patent_doc_number] => 20220282225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Enzyme And Application Thereof
[patent_app_type] => utility
[patent_app_number] => 17/700237
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700237 | Enzyme and application thereof | Mar 20, 2022 | Issued |
Array
(
[id] => 18036022
[patent_doc_number] => 20220380237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CONTAMINATED WATER
[patent_app_type] => utility
[patent_app_number] => 17/700461
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700461 | COMPOSITIONS AND METHODS FOR TREATING CONTAMINATED WATER | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19140481
[patent_doc_number] => 20240139270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/278731
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278731
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278731 | COMPOSITIONS | Feb 22, 2022 | Abandoned |
Array
(
[id] => 18733417
[patent_doc_number] => 11802140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Treatment of ischemia
[patent_app_type] => utility
[patent_app_number] => 17/669844
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 36
[patent_no_of_words] => 14399
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669844 | Treatment of ischemia | Feb 10, 2022 | Issued |